Advisors Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Advisors Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,743	Closed	-$3.73M	–	1557
2017 Q3	$3.73M	Buy	20,743 +932	+5%	+$130K	0.06%	423
2017 Q2	$2.05M	Buy	19,811 +1,412	+8%	+$115K	0.03%	615
2017 Q1	$1.44M	Buy	18,399 +8,242	+81%	+$510K	0.02%	747
2016 Q4	$455K	Buy	10,157 +5,142	+103%	+$252K	0.01%	1157
2016 Q3	$280K	Buy	+5,015	New	+$279K	﹤0.01%	1271

Advisors Asset Management's KITE Position: Q4 2017 in Review

Advisors Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 20,743 shares — an estimated $3.73M sold.

Advisors Asset Management first reported a position in KITE in Q3 2016 and held it in 5 quarters. The position peaked at $3.73M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Advisors Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Advisors Asset Management sold 20,743 Kite Pharma, Inc. shares in Q4 2017, an estimated $3.73M.
Advisors Asset Management first reported a position in Kite Pharma, Inc. in Q3 2016 and held it in 5 quarters.
Advisors Asset Management's Kite Pharma, Inc. position peaked at $3.73M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Advisors Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.